BRANDON TERRY: Open Payments
NPI 1477048536 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 40 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $334 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $177 |
| ABBVIE INC. | 9 | $160 |
| PFIZER INC. | 3 | $128 |
| Organon LLC | 8 | $123 |
| GENZYME CORPORATION | 5 | $111 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $40 |
| Amgen Inc. | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, CIBINQO, TALTZ, Otezla, VTAMA, Winlevi.
Industry payments across MD — which companies pay providers there.
